Mr. Saran has served as executive vice president, corporate development and general counsel, since May 2017. Prior to joining Emergent, Mr. Saran served as senior vice president and general counsel at MacroGenics from April 2014 to May 2017.
Previously, Mr. Saran served in various leadership roles at AstraZeneca and MedImmune from 2003 through 2014, including vice president, corporate development and ventures at AstraZeneca and chairman of the MedImmune Ventures investment committee from May 2013 to January 2014; senior vice president, corporate development and ventures from January 2011 to May 2013; and positions of increasing responsibility in the MedImmune legal department from 2003 through 2010, culminating as vice president and deputy general counsel. Before his time at MedImmune, Mr. Saran was an associate attorney in the business and finance group at Hogan & Hartston.
Mr. Saran is an active board member of LogicNets, Inc. He has served on the board of directors for several other companies including VentiRx Pharmaceuticals, Xencor, Inotek Pharmaceuticals and Arriva Pharmaceuticals.
Mr. Saran holds a J.D. from the University of Illinois College of Law, an M.B.A. from the MIT Sloan School of Management and a B.S. in Biological Sciences from Stanford University.